• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Merck/GSK schedule


<



That's what happens when we can't supply product, and then lie about how long before it's coming back. Merck wins because Gsk is conceding Rotarix to get pediatric and boostrix in the door. Plus Merck gains PedVax. Add in Menveo and we are screwed. This company is piss poore in the management of this pentacel fuck up!